EBITDA CAGR uses clean operating EBITDA derived from reported operating income plus depreciation and amortization.
Over the past 12 months, EBITDA CAGR is -92.95%. EBITDA CAGR shows how the company's operating profitability has grown before depreciation and amortization. This reflects the growth of the core business's cash-operating earnings power, independent of capital-intensity and accounting depreciation choices.
BNTX EBITDA CAGR Chart
BioNTech SE (BNTX)
tgmcharts.com
BNTX Quarterly EBITDA Growth (YoY)
EBITDA growth vs the same quarter one year earlier, last 16 quarters.
tgmcharts.com
EBITDA
BNTX Quarterly EBITDA
$-778.97M
Reported quarterly EBITDA; no daily interpolation.
